Family Planning Centers
Industry Profile Report
Dive Deep into the industry with a 25+ page industry report (pdf format) including the following chapters
Industry Overview Current Conditions, Industry Structure, How Firms Operate, Industry Trends, Credit Underwriting & Risks, and Industry Forecast.
Call Preparation Call Prep Questions, Industry Terms, and Weblinks.
Financial Insights Working Capital, Capital Financing, Business Valuation, and Financial Benchmarks.
Industry Profile Excerpts
Industry Overview
The 2,500 family planning centers in the US provide a variety of outpatient services, including contraceptive services, genetic and prenatal counseling, voluntary sterilization, and therapeutic and medically-induced termination of pregnancy. Although the majority of clients at family planning centers are women, most establishments offer services for men also. Non-profit organizations account for 75% of establishments and 55% of revenue.
Controversial Services
Certain services offered by family planning centers are controversial and have been the topic of debate for decades.
Competition From Alternative Service Providers
Family planning centers face competition from a variety of alternative service providers, including state and local health departments, physicians, hospitals, general health clinics, school clinics, urgent care clinics, and other health care providers.
Industry size & Structure
The average family planning center employs 15-16 workers and generates $1.4 million annually.
- The family planning center industry consists of about 2,500 establishments that employ 23,500 workers and generate over $3 billion annually.
- Nonprofit organizations account for 75% of establishments and 55% of revenue. For-profit organizations account for 25% of establishments and 45% of revenue.
- Organizations that offer family planning services include federally qualified health centers (FQHC) and clinics, state health departments, Planned Parenthood affiliates, and other independent agencies, such as family planning councils.
- The industry is concentrated at the top and fragmented at the bottom; the top 50 organizations account for 59% of industry revenue.
Industry Forecast
Family Planning Centers Industry Growth
Recent Developments
Mar 19, 2024 - Moderate Sales Growth Expected
- Family planning industry sales are forecast to increase at a 6.46% compounded annual rate from 2022 to 2027, faster than the growth of the overall economy, according to Inforum and the Interindustry Economic Research Fund, Inc. Industry labor costs increased during 2023 as employment increased moderately while average wages for nonsupervisory employees increased slightly, according to the US Bureau of Labor Statistics.
- CVS and Walgreens, the two largest drug store chains in the US, will start offering the abortion pill mifepristone in March, according to The New York Times. The chains plan to initially offer mifepristone at stores in just a few states and gradually expand to all other states where they can legally do so. About half of US states allow the sale of mifepristone. The pills won't be sold by mail. Doctors and other eligible providers will be able to call in a prescription to a pharmacy for a patient to pick up.
- Some abortion opponents are seeking ways to limit the ability of residents of states with total bans to access abortion in other states, according to nonprofit news organization The 19th. Clinics in states such as Florida, Illinois, New Mexico, Kansas, and Colorado — all close to states with near-total abortion bans — have reported major increases in the number of patients, with the majority often coming from out of state, according to The 19th. Opponents are said to be relying on new legal strategies and targeting people who assist those who are traveling to facilities in other states. Alabama’s attorney general has declared that his office can use criminal conspiracy laws to prosecute people who helped residents leave the state for an abortion but he has not leveraged that authority, leaving the legal basis untested. Some counties in Texas have passed ordinances that would outlaw using their roads to drive someone out of state for an abortion. These measures would largely be enforced by civil lawsuit rather than criminal punishment.
- Food and Drug Administration (FDA) decisions to allow the drug mifepristone to be taken later in pregnancy, be mailed directly to patients, and be prescribed by a medical professional other than a doctor were not lawful, a three-judge panel of the US Court of Appeals for the 5th Circuit ruled. The panel ruled that the FDA did not follow the proper process when it loosened regulations in 2016 to make the pill more easily available. Mifepristone will remain available for now under existing regulations while the litigation continues, in accordance with a Supreme Court order this spring. The US Department of Justice said that it will go to the US Supreme Court to appeal the decision, which only partially upheld a lower-court judge’s ruling in favor of a coalition of antiabortion challengers.
Get A Demo
Vertical IQ’s Industry Intelligence Platform
See for yourself why over 60,000 users trust Vertical IQ for their industry research and call preparation needs. Our easy-to-digest industry insights save call preparation time and help differentiate you from the competition.
Build valuable, lasting relationships by having smarter conversations -
check out Vertical IQ today.